These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 22257645

  • 21. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J.
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 24. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R.
    Osteoporos Int; 2008 May; 19(5):699-707. PubMed ID: 18084691
    [Abstract] [Full Text] [Related]

  • 25. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE, Mesure R.
    Br J Clin Pharmacol; 1995 May; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone.
    Zimmerman Y, Wouters W, Coelingh Bennink HJ.
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):206-14. PubMed ID: 23550808
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa.
    Singhal V, Nimmala S, Slattery M, Eddy KT, Miller KK, Klibanski A, Misra M.
    Nutrients; 2022 Jun 21; 14(13):. PubMed ID: 35807738
    [Abstract] [Full Text] [Related]

  • 37. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM.
    J Clin Endocrinol Metab; 2006 Aug 21; 91(8):2986-93. PubMed ID: 16735495
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
    Strokosch GR, Friedman AJ, Wu SC, Kamin M.
    J Adolesc Health; 2006 Dec 21; 39(6):819-27. PubMed ID: 17116511
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.